Annual Accounts Payable
$4.53 M
+$1.44 M+46.48%
December 31, 2023
Summary
- As of February 7, 2025, AVBP annual accounts payable is $4.53 million, with the most recent change of +$1.44 million (+46.48%) on December 31, 2023.
- During the last 3 years, AVBP annual accounts payable has risen by +$4.24 million (+1446.76%).
- AVBP annual accounts payable is now at all-time high.
Performance
AVBP Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$4.53 M
+$720.00 K+18.89%
September 1, 2024
Summary
- As of February 7, 2025, AVBP quarterly accounts payable is $4.53 million, with the most recent change of +$720.00 thousand (+18.89%) on September 1, 2024.
- Over the past year, AVBP quarterly accounts payable has increased by +$720.00 thousand (+18.89%).
- AVBP quarterly accounts payable is now -29.82% below its all-time high of $6.46 million, reached on June 1, 2023.
Performance
AVBP Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
AVBP Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +46.5% | +18.9% |
| 3 y3 years | +1446.8% | +18.9% |
| 5 y5 years | +1446.8% | +18.9% |
AVBP Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +1446.8% | -29.8% | +46.5% |
| 5 y | 5-year | at high | +1446.8% | -29.8% | +46.5% |
| alltime | all time | at high | +1446.8% | -29.8% | +46.5% |
ArriVent BioPharma Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $4.53 M(+18.9%) |
| Jun 2024 | - | $3.81 M(-7.0%) |
| Mar 2024 | - | $4.10 M(-9.6%) |
| Dec 2023 | $4.53 M | $4.53 M(-5.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $4.82 M(-25.4%) |
| Jun 2023 | - | $6.46 M(+108.7%) |
| Dec 2022 | $3.09 M(+956.0%) | - |
| Dec 2022 | - | $3.09 M |
| Dec 2021 | $293.00 K | - |
FAQ
- What is ArriVent BioPharma annual accounts payable?
- What is the all time high annual accounts payable for ArriVent BioPharma?
- What is ArriVent BioPharma annual accounts payable year-on-year change?
- What is ArriVent BioPharma quarterly accounts payable?
- What is the all time high quarterly accounts payable for ArriVent BioPharma?
- What is ArriVent BioPharma quarterly accounts payable year-on-year change?
What is ArriVent BioPharma annual accounts payable?
The current annual accounts payable of AVBP is $4.53 M
What is the all time high annual accounts payable for ArriVent BioPharma?
ArriVent BioPharma all-time high annual accounts payable is $4.53 M
What is ArriVent BioPharma annual accounts payable year-on-year change?
Over the past year, AVBP annual accounts payable has changed by +$1.44 M (+46.48%)
What is ArriVent BioPharma quarterly accounts payable?
The current quarterly accounts payable of AVBP is $4.53 M
What is the all time high quarterly accounts payable for ArriVent BioPharma?
ArriVent BioPharma all-time high quarterly accounts payable is $6.46 M
What is ArriVent BioPharma quarterly accounts payable year-on-year change?
Over the past year, AVBP quarterly accounts payable has changed by +$720.00 K (+18.89%)